This review explores the potential of high-sensitivity C-reactive protein (hsCRP) as an independent predictor of cardiovascular events in patients with diabetes mellitus. By assessing systemic inflammation, hsCRP levels offer clinicians a valuable tool for identifying diabetic individuals at elevated cardiovascular risk, improving risk stratification and informing targeted preventive strategies.
